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Summary
Plasmodium sporozoites make a remarkable journey
from the skin, where they are deposited by an infected
Anopheline mosquito, to the liver, where they invade
hepatocytes and develop into exoerythrocytic stages.
Although much work has been done to elucidate the
molecular mechanisms by which sporozoites invade
hepatocytes, little is known about the interactions
between host and parasite before the sporozoite
enters the blood circulation. It has always been
assumed that sporozoites rapidly exit the injection
site, making their interactions with the host at this
site, brief and difficult to study. Using quantitative
PCR, we determined the kinetics with which sporozoi-
tes leave the injection site and arrive in the liver and
found that the majority of infective sporozoites
remain in the skin for hours. We then performed sub-
inoculation experiments which conﬁrmed these ﬁnd-
ings and showed that the pattern of sporozoite exit
from the injection site resembles a slow trickle. Last,
we found that drainage of approximately 20% of the
sporozoite inoculum to the lymphatics is associated
with a signiﬁcant enlargement of the draining lymph
node, a response not observed after intravenous
inoculation. These ﬁndings indicate that there is
ample time for host and parasite to interact at the
inoculation site and are of relevance to the pre-
erythrocytic stage malaria vaccine effort.
Introduction
Infection of the mammalian host with malaria is initiated
when Plasmodium sporozoites, present in the salivary
glands of an infected Anopheles mosquito, are introduced
into the skin with the saliva as the mosquito probes for
blood. The sporozoites enter the blood circulation and
then reach and invade their unique target cell, the
hepatocyte. At the end of this obligatory, clinically silent
and relatively short hepatic multiplication step, merozoites
are released into the blood stream where they invade and
multiply in red blood cells. All the clinical symptoms of
malaria are associated with the erythrocytic phase of the
infection which generally lasts for many months in the
absence of treatment. Thus, the pre-erythrocytic stages,
when parasite numbers are comparatively low, provide an
excellent target for vaccines aimed at preventing infection
(Sinnis and Nussenzweig, 1996).
It has long been thought that sporozoites reach the liver
quickly following the mosquito bite. Indeed, sub-
inoculation experiments in humans have demonstrated
that sporozoites appear in the circulation even while the
infected mosquito is feeding (Fairley, 1947). In addition,
the demonstration, in vitro, that sporozoite infectivity
wanes rapidly following incubation at 37°C, has sug-
gested that this infective stage must reach its target organ
within 1 h (Vanderberg, 1975). Thus, the perception is that
sporozoites as well as merozoites, the other infective form
of Plasmodium in the mammalian host, must quickly
invade their target cell, before they lose infectivity or are
destroyed by the host immune system.
Recent studies show that the majority of sporozoites
are injected into the skin of the mammalian host and not
directly into the blood circulation (Sidjanski and Vander-
berg, 1997; Matsuoka et al., 2002; Medica and Sinnis,
2005), a ﬁnding that is not unexpected given that mosqui-
toes salivate while they are probing for blood but not when
they are imbibing blood. After their injection into the
dermis, video microscopic observations of ﬂuorescent
Plasmodium berghei sporozoites elegantly demonstrated
that sporozoites move randomly in the dermis until con-
tacting dermal blood vessels which they penetrate, thus
entering the blood circulation and exiting the inoculation
site (Amino et al., 2006). In the present study, we analy-
sed the fate of sporozoites deposited in the skin over an
extended period of time using techniques that allowed us
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Results
In the following experiments we used the rodent parasite
Plasmodium yoelii because infectivity of its sporozoites to
laboratory rodents is signiﬁcantly higher than that of
P. berghei (Weiss, 1990; Khan and Vanderberg, 1991;
Khusmith et al., 1991), thus allowing us to conduct mean-
ingful quantitative studies of hepatic parasite loads. We
ﬁrst wished to establish the kinetics of sporozoite exit out
of the inoculation site. Five thousand P. yoelii sporozoites
dissected from salivary glands were injected intradermally
into the distal portion of the pinna of one ear of each
mouse.At different time points after injection, the segment
of the ear in which the sporozoites were introduced was
removed and the number of remaining sporozoites was
estimated by quantitative PCR. In preliminary studies, no
decrease in the sporozoite loads could be noted when the
ears were harvested at 10 and 30 min after injection (data
not shown). The observation period was therefore
extended. As shown in Fig. 1, most of the injected sporo-
zoites were still present in the ear 1 h after inoculation,
and a signiﬁcant decrease in sporozoite numbers was
observed 3 h post injection. The large variation in the
number of sporozoites present in the 3 h samples was
consistently observed (four experiments with four mice/
group/experiment), suggesting that at this time, the major-
ity of sporozoites were in the process of leaving the
inoculation site or being destroyed. It is interesting to note
that a minor proportion of sporozoites could still be repro-
ducibly detected in the ear at 18 and 42 h post injection.
In the above experiments, it was not possible to distin-
guish between removal of parasites by in situ destruction
(i.e. via innate host responses) or by their successful entry
into the blood circulation. We employed two complemen-
tary approaches to address this question, namely reverse
transcription followed by quantitative PCR (RT-PCR) and
sub-inoculation.
In the ﬁrst set of experiments, the intradermal inocula-
tion site was removed at different time points after injec-
tion and the parasite liver load was determined 40 h later
by RT-PCR. Using this methodology, only sporozoites
which have invaded hepatocytes and undergone many
cycles of replication are detectable because the small
amount of rRNA present in the injected sporozoites or in
early liver stages is below the sensitivity of the assay
(Briones et al., 1996). As shown in Fig. 2A, the majority of
inoculated sporozoites that would ultimately productively
infect the liver, took over 1 h to exit the dermis. By 3 h post
injection most of the infective sporozoites had left the site;
however, we consistently observed a large amount of
variability in liver stage infection when the injection site
was removed at this time point (ﬁve experiments, ﬁve
mice/group/experiment). This variability parallels the vari-
able numbers of sporozoites remaining at the injection
site at this time point (Fig. 1).
In order to determine whether this pattern of sporozo-
ite release occurs under natural conditions of transmis-
sion, i.e. through mosquito bite rather than by needle
injection, we repeated the experiments by allowing 20
infected mosquitoes to feed on each mouse. We
selected two different sites for biting that differ in the
extent of vascularization: the ear and the back. Overall,
the pattern of sporozoite release observed when sporo-
zoites were injected by mosquitoes was similar to what
we found with needle injection (Fig. 2A–C). However,
when sporozoites were injected by mosquito bite into the
ear, fewer parasites had left the site at 3 h post inocula-
tion compared with sporozoites that were injected either
by needle into the ear or by mosquito bite into the back.
This difference might reﬂect the lower density of blood
vessels in the ear compared with the back and indicates
that tissue damage due to needle insertion might have
accelerated the rate of sporozoite exit from the ear.
Taken together, the data clearly show that regardless of
the inoculation site, sporozoites do not leave the injection
site in appreciable numbers before 1 h. After this time
point, however, the kinetics of sporozoite exit may
depend upon factors, such as the density of the vascular
bed and the extent of capillary damage, which may inﬂu-
ence the ease with which the blood circulation can be
accessed. Finally, it should be noted that fewer sporo-
zoites were injected by mosquitoes than by needle
[1500, assuming an average of 75 sporozoites per mos-
quito (Medica and Sinnis, 2005) versus 4000 sporozoites
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Fig. 1. Kinetics with which sporozoites disappear from the
inoculation site. Mice were injected intradermally in the ear with
5000 P. yoelii sporozoites, the ears were removed at the indicated
time points and the number of sporozoites in each ear was
quantiﬁed by PCR. There were four mice per group and the
means  standard deviations are shown.
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observed in the mosquito-bitten mice.
These experiments suggested that the majority of infec-
tious sporozoites take hours to exit the injection site. To
verify these data and conﬁrm that infectivity does not
decline substantially in sporozoites released later rather
than earlier after inoculation, we performed blood sub-
inoculation experiments. Donor mice were injected with
25 000 sporozoites and at different time points after injec-
tion the animals were bled by cardiac puncture. The blood
from one donor was divided and inoculated intravenously
into each of three naïve recipients. Recipient mice were
monitored for blood stage infection in order to determine
whether the transferred blood contained infectious
sporozoites. In initial experiments, we used intravenously
inoculated donors in order to establish that infectious
sporozoites could indeed be transferred from donor to
recipient by blood transfer and to examine the kinetics
with which circulating sporozoites were cleared from the
blood. These experiments established that once in the
circulation, infective sporozoites are cleared in less than
30 min (Fig. 3A); none of the mice receiving blood col-
lected from donor mice at 30 min or more after sporozoite
inoculation, became positive. When sub-inoculation
experiments were performed using blood from donor mice
that had been injected intradermally with 25 000 sporo-
zoites, the results were strikingly different (Fig. 3B). Irre-
spective of the time that donor blood was collected, about
half of the recipient mice became infected, demonstrating
that the pool of inoculated sporozoites in the skin is con-
tinuously replenishing the blood circulation with infective
sporozoites.
The hepatic stage of P. yoelii is completed between 45
and 48 h, ending with the release of merozoites into the
blood stream, where they invade red blood cells and
multiply every 18 h. When the sporozoite inoculum is
large (> 1000 sporozoites) parasites can be observed in
the blood starting from day 3 post sporozoite inoculation
(Gantt et al., 1998). As shown in Fig. 3A, the majority of
recipients given blood from intravenously injected donors
had a pre-patent period of 3 days, an expected result
given the large numbers of sporozoites that we injected
into these donor mice. A 1 day delay in the pre-patent
period is considered to indicate a ﬁve- to 10-fold decrease
in the inoculum and we have previously established that
mice inoculated intravenously with 100 sporozoites of the
same P. yoelii line become patent on day 4 post inocula-
tion (Gantt et al., 1998). Thus, given the observed pre-
patent periods in the recipients of blood from intradermally
inoculated donors, it is likely that infective sporozoites are
transiting from the skin to the blood at a slow steady rate,
at least for the ﬁrst 2 h post inoculation (Fig. 3B).
In order to determine whether the route of sporozoite
inoculation alters the effective inoculum size, 5000 sporo-
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Fig. 2. Kinetics of sporozoite arrival in the liver. Mice were
inoculated intradermally in the ear with 4000 P. yoelii sporozoites
(A), exposed to 20 infective mosquito bites, 10 in each ear (B), or
20 infective mosquito bites in the back (C) and the injection site
was removed at the indicated time points. Control mice had the
uninjected ear removed at 3 h (A), no ears removed (B) or an
adjacent uninjected site removed at 3 h (C). Forty hours after
sporozoite inoculation, mice were sacriﬁced and liver parasite
burden was quantiﬁed by RT-PCR. There were ﬁve (A) or eight (B
and C) mice per group and the means  standard deviations are
shown.
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two separate groups of animals, and the parasite liver
load was determined 40 h later. As shown in Fig. 4, the
difference in parasite loads was not signiﬁcant, though
variability was higher for animals inoculated intravenously,
a ﬁnding that was consistently observed (three experi-
ments, four to ﬁve mice/group/experiment). The variability
observed with intravenously inoculated sporozoites could
reﬂect differences in ﬁtness of the sporozoites reaching
the liver. These differences might not be present in sporo-
zoites that have had to go through the dermis.
Next we wished to determine whether P. yoelii sporo-
zoites trafficked to the draining lymph node after their
injection into the skin. We therefore injected P. yoelii
sporozoites intradermally into mouse ears and performed
PCR quantiﬁcation of total genomic DNA puriﬁed from the
dissected ipsilateral auricular lymph node that drains the
ear injection site.As shown in Fig. 5A, approximately 20%
of the P. yoelii sporozoites reach the lymphatics. The
kinetics of appearance of sporozoites in these lymph
nodes parallels that of the migration out of the inoculation
site, in that the largest numbers of sporozoites appear in
the lymph node 3 h after inoculation. By 6 h post injection,
few sporozoites are detectable in the lymph nodes. As
lymph nodes are an important site of immunological
priming, we wished to ascertain whether transit of sporo-
zoites altered the lymph nodes. To this end, we measured
the size of the lymph nodes draining the ear in which
sporozoites were inoculated 6 days previously. Signiﬁcant
enlargement of these lymph nodes was speciﬁcally asso-
ciated with the site of intradermal inoculation as the lymph
nodes draining the uninjected ear were not enlarged (data
not shown). In addition, intravenous inoculation of equal
numbers of sporozoites did not result in lymph node
enlargement (Fig. 5B and C). The observed enlargement
was not accounted for by the salivary gland debris present
in the inoculum, because the lymph nodes of mice
injected with material obtained from an equivalent number
of uninfected mosquitoes were found to be signiﬁcantly
less enlarged (P < 0.001; Fig. 5B and C). When sporozoi-
tes were inoculated by infected mosquitoes, the draining
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Fig. 3. Intradermally injected sporozoites are slowly released from
the injection site into the bloodstream. Donor mice were injected
with 25 000 P. yoelii sporozoites either intravenously (A) or
intradermally (B). At the indicated time points after injection, donor
mice were exsanguinated by cardiac puncture and one-third of the
recovered blood (~300 ml) was injected intravenously into each
recipient mouse, which was then monitored for the presence of
blood stage parasites beginning on the third day after inoculation.
x-axis, the time of blood transfer from the donor; y-axis, the
proportion of recipient mice that became positive for erythrocytic
stage parasites; z-axis, the pre-patent period for the mice that
became positive. Shown are the combined data from three
experiments. There were four to six donors and 10–18 recipients
per time point.
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Fig. 4. Sporozoite infectivity after intradermal versus intravenous
inoculation. Mice were inoculated with 5000 P. yoelii sporozoites by
intravenous or intradermal injection and 40 h later they were
sacriﬁced and liver parasite burden was quantiﬁed by RT-PCR.
There were ﬁve mice per group and shown are the
means  standard deviations.
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degree observed with intradermal injection. These data
suggest that the extent of enlargement is correlated to the
number of sporozoites transiting through the lymph nodes
because a median of 750 sporozoites would be expected
to be inoculated by 10 infected mosquitoes, as compared
with the 5000 injected intradermally. The anterior cervical
lymph nodes, the nodes distal to those draining the ear,
were not enlarged in the mice receiving 5000 sporozoites
intradermally (data not shown). This suggests that the
sporozoites draining to the lymphatics are destroyed,
though this remains to be formally demonstrated.
Discussion
The data presented in this study uncover two hitherto
unsuspected facets of the biology of the Plasmodium
sporozoite. The infective sporozoites inoculated by the
mosquito are released from the skin into the blood circu-
lation in a trickle extending for hours after the mosquito
bite. Thus, sporozoites retain infectivity for prolonged
periods following their transition to the mammalian host. It
is likely that a factor(s) in the skin preserves the infectivity
of the inoculated sporozoites for a number of hours. This
is in contrast to the rapid loss of infectivity observed in
sporozoites placed in vitro at 37°C in physiological media.
Our data raise the possibility that the other infective form
in the mammalian host, the merozoite, might also retain
infectivity in vivo for longer periods than has been
assumed from in vitro observations.
A recent study showed that saliva introduced into the
skin during mosquito feeding can trigger degranulation of
cutaneous mast cells and dermal inﬁltration by neutrophils
(Demeure et al., 2005). As the majority of sporozoites
spend 1–2 h at the injection site, they may encounter
these activated cells. The effect of these mosquito-
induced innate immune responses on sporozoite infectiv-
ity remain to be elucidated. Speciﬁcally, it will be of
interest to know the precise timing of mast cell degranu-
lation and neutrophil inﬁltration in order to determine the
role, if any, that innate immunity plays in the very early
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Fig. 5. A proportion of intradermally injected sporozoites go to the
draining lymph node.
A. Five thousand P. yoelii sporozoites were injected into one ear of
each mouse and at the indicated time points the ipsilateral auricular
lymph node was removed and parasite numbers were quantiﬁed by
PCR. There were ﬁve mice per group and shown are the
means  standard deviations.
B. Mice were injected in the left ear either intradermally with
medium alone (Naive), 5000 P. yoelii sporozoites intravenously (IV
Spz), salivary gland homogenates intradermally (ID Uninf), or 5000
P. yoelii sporozoites intradermally (ID Spz) or fed upon by 10
uninfected mosquitoes (MB Uninf) or 10 infected mosquitoes (MB
Inf) and 6 days later the left auricular lymph node was removed,
ﬁxed and photographed. Bar = 1 mm.
C. Lymph nodes from the mice in B were weighed. There were ﬁve
mice per group and shown are the means  standard deviations.
Student’s t-test for unpaired data showed that the weights of the
lymph nodes of mice injected intradermally with sporozoites was
signiﬁcantly different from those of mice injected intradermally with
uninfected salivary glands (*P < 0.001) and the weights of lymph
nodes of mice bitten by infected mosquitoes was signiﬁcantly
different from those bitten by uninfected mosquitoes (**P < 0.01).
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data that sporozoites remaining in the skin after 3 h are
destroyed as we consistently see robust sporozoite
signals in the skin beyond 3 h (Fig. 1A) but fail to see a
statistically signiﬁcant increase in liver infectivity when the
injection site is removed 3 h after sporozoite inoculation
(data not shown). Undoubtedly this will be a fruitful area of
future investigation.
The data we present here with P. yoelii are largely
complementary to the recently published study in which
early events in P. berghei sporozoite infection were
studied by intravital microscopy (Amino et al., 2006). In
that study, however, sporozoites were observed to lose
motility by 1 h after their inoculation, suggesting that they
were no longer infectious after this time. The difference
between our studies could reﬂect differences between the
biology of the two Plasmodium species used or differ-
ences in the skin environment of the mouse strains used.
Another possible explanation is that prolonged micro-
scopic observation of the inoculation site led to an
increase of temperature which adversely affected sporo-
zoite motility.
There are two studies in humans relevant to our obser-
vations in the mouse model. First, in a seminal study
where the length of the pre-erythrocytic cycle was estab-
lished (Fairley, 1947), the presence of infectious sporo-
zoites in the blood was assessed by transfusion of blood
from donors exposed to the bites of Plasmodium
falciparum-o rPlasmodium vivax-infected mosquitoes into
naïve recipients. In one set of experiments, transfusions
were performed at times ranging from ‘during biting’ to 2 h
after biting ceased. Seven of a total of 16 recipients
became positive for blood-stage parasites and two of the
seven were transfused with blood at later time points, i.e.
30 min and 60 min after cessation of mosquito biting. In
the other experiments, transfusions were carried out with
blood collected on days 1–8 after mosquito biting and
none of these recipients became infected. Although these
observations do not offer conclusive demonstration, they
are consistent with the occurrence of a trickle of sporo-
zoites from the skin into the circulation. However, there
are limitations inherent in using human volunteers that
limit the types of data one can gather. Fairley was
restricted in the number of human volunteers he could
use, the number of infective bites to which human sub-
jects were exposed, and the volume of blood he could
withdraw from the donor and transfuse into the recipient.
Using the rodent system we were able to increase the
initial sporozoite inoculum by an order of magnitude, to
inject a much larger percentage of the donor’s blood
volume into recipients (75% of the donor’s blood volume
into three recipients versus 4–10% of the donor’s blood
volume into one recipient) and to use larger numbers of
recipients (10–18 recipients per time point versus one to
four recipients per time point), all of which likely contrib-
uted to our ability to quantitatively observe infectious
sporozoites as they entered the blood circulation. The
other study of relevance to our work is the work of Boyd
and Kitchen (1939) who observed intact P. vivax sporo-
zoites in a lymph node 24 h after mosquito bite, a clear
indication that sporozoites can survive outside the blood
stream for long periods of time. Taken together these
observations suggest that sporozoites might behave in a
similar manner in humans and rodents.
The slow release of sporozoites from the skin into the
circulation and the ﬁnding of a proportion of the inoculum
in the lymph node are of potential signiﬁcance to current
efforts to develop and optimize vaccines targeting the
pre-erythrocytic stages of Plasmodium (Luke and
Hoffman, 2003; Hill, 2006). Prolonged residence of sporo-
zoites in the skin adds to the time during which this extra-
cellular parasite form would be exposed to immune
attack, and comforts the notion that induction of neutral-
izing antibodies to sporozoites should remain a focus of
the malaria vaccine community. Exposure of antigen pre-
senting cells, present in the lymph nodes, to signiﬁcant
amounts of sporozoite antigens raises the possibility that
sporozoites introduced into the mammalian host by
natural infection may induce a qualitatively different
immune response than that induced by intravenous
inoculation.
Experimental procedures
Parasites
Three- to ﬁve-day-old Anopheles stephensi mosquitoes were fed
on anaesthetized P. yoelii (clone 17X)-infected Swiss Webster
mice with abundant gametocyte-stage parasites. Salivary gland
sporozoites were harvested on days 14–15 post infective blood
meal. The mosquitoes were rinsed in 70% ethanol and washed in
Dulbecco’s Modiﬁed Eagle Medium (DMEM) before salivary
gland dissection. The glands were gently homogenized, spun at
80 g for 3 min, to remove mosquito debris, the sporozoite-
containing supernatant was removed and sporozoites counted in
a haemocytometer.
Quantiﬁcation of parasites in the skin and lymph node
Four- to six-week-old Swiss Webster mice were anaesthetized
and maintained at 37°C on a slide warmer. A total of 5000
sporozoites (in 5 ml DMEM) were inoculated by intradermal injec-
tion into the pinna of the ear with a Flexiﬁll microsyringe (World
Precision Instruments, Sarasota, FL). The injected ears and ipsi-
lateral auricular lymph nodes were removed at the indicated time
points, weighed, cut into small pieces, and digested overnight at
50°C with proteinase K. Genomic DNA was extracted using the
DNeasy tissue kit (QIAGEN, Valencia, CA) and parasite genomic
DNA was quantiﬁed using nested PCR followed by real-time
PCR. For nested PCR, we used 100 ng of total genomic
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primer, 5′-ctaattagcggcgagtacgctatatcc and reverse primer,
5′-ctaaggacatcacagacctgttgtttgc. These sequences are found
67 bp upstream and 34 bp downstream, respectively, of the
primers used in the subsequent real-time PCR. The cycling
proﬁle was 95°C for 3 min followed by 15 cycles of: 95°C, 30 s;
60°C, 30 s; 72°C, 30 s; and a ﬁnal extension of 72°C for 5 min.
Quantitative PCR analysis was then performed in a Rotor-Gene
3000 (Corbett Life Science, Sydney, Australia) using 5 mlo ft h e
nested PCR, 5 rM each of forward (5′-ggggattggttttgacgtttttgcg)
and reverse (5′-aagcattaaataaagcgaatacatccttat) primers
(Bruna-Romero et al., 2001) and the QuantiTect SYBR green
PCR kit (Qiagen, Valencia, CA). Parasite numbers were deter-
mined using a standard curve made from mouse ears or lymph
nodes spiked with 0, 200, 1000 and 5000 sporozoites. Genomic
DNA was isolated and processed from these samples as
described for the experimental tissue samples.
Quantiﬁcation of parasites in the liver
Swiss Webster mice were anaesthetized and maintained at 37°C
on a slide warmer. Four thousand sporozoites were inoculated by
intradermal injection with the Flexiﬁll microsyringe into the pinna
of one ear. At the indicated time points, mice were anaesthetized
again and the injected ear was removed using a surgical scissors
under aseptic conditions. Control mice had the uninjected ear
removed 3 h post sporozoite inoculation. Forty hours after sporo-
zoite inoculation, the livers of all mice were harvested, total RNA
was isolated using Tri-reagent (Molecular Research Center, Cin-
cinnati, OH) and the parasite burden in the liver was quantiﬁed
using reverse transcription (RT) followed by real-time PCR as
outlined in Bruna-Romero et al. (2001). RT was performed using
1 mg of total RNA and random hexamers and real-time PCRs
were performed using primers that recognize P. yoelii-speciﬁc
sequences within the 18S rRNA(Bruna-Romero et al., 2001) and
the QuantiTect SYBR Green PCR Kit (QIAGEN, Valencia, CA).
Liver infection was quantiﬁed by comparison with a standard
curve made from livers of mice that had been injected intrave-
nously with 10, 100, 1000 or 10 000 sporozoites. For the experi-
ments in which sporozoites were injected by mosquito bite, 10
mosquitoes were allowed to probe for 3 min on each ear. Both
ears were removed at the indicated time points and control mice
did not have their ears removed. In experiments where sporozoi-
tes were injected by mosquito bite into the back, the hair was
removed from the back 1 day prior to the experiment and the skin
was pinched up during feeding so that sporozoites would only be
deposited in the dermis and not in the muscle layer beneath the
dermis. Twenty mosquitoes were allowed to probe on an area
that was 1 cm in diameter which was then removed at the indi-
cated time points. In control mice a 1 cm area adjacent to the
probed-upon area was removed. Removal of the injection site or
control area was performed in a sterile dissection hood using
aseptic technique on anaesthetized mice and the wound was
closed with 3.0 silk sutures.
Sub-inoculation experiments
Six-week-old Balb/C mice were anaesthetized, maintained on a
slide warmer at 37°C and injected either intravenously or intrad-
ermally with 2.5 ¥ 10
4P. yoelii sporozoites. Shortly before the indi-
cated time points the mouse was anaesthetized again and then
bled by cardiac puncture using heparin (100 units ml-1)a sa n
anticoagulant. Between 0.6 and 0.9 ml of blood was obtained
from each mouse. Three hundred microlitres of collected blood
was inoculated intravenously into each recipient Balb/C mouse.
Recipients were monitored for the presence of erythrocytic stage
parasites by Giemsa-stained blood smears until day 20 after
blood inoculation.
Lymph nodes
Mice were inoculated intradermally in the ear with either 5000
P. yoelii sporozoites, an equivalent amount of salivary gland
material from uninfected mosquitoes, the bites of 10 P. yoelii-
infected mosquitoes, the bites of 10 uninfected mosquitoes or
medium alone. Another group was injected intravenously with
5000 P. yoelii sporozoites. Six days later the ipsilateral auricular
lymph node was removed from each mouse, ﬁxed in 4%
paraformaldehyde at 4°C, weighed, measured and photographed
with a Leica M3Z dissecting microscope with an attached Optron-
ics CCD camera, using Magnaﬁre 2.0 image software.
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